CoNextions Medical, Inc.

CoNextions Medical, Inc. is dedicated to providing innovative orthopedic solutions that enhance the effectiveness of soft tissue repairs, particularly in tendon surgeries, through advanced medical devices designed for optimal surgical outcomes. Founded in 2011, CoNextions Medical, Inc. is based in Salt Lake City, US.

The company specializes in developing orthopedic solutions, focusing on innovative products for soft tissue repair. CoNextions Medical has completed a total of six deals, with its most recent funding round occurring in December 2018, when it raised USD 1. 11 mn. The company's leadership includes CEOs Dan Gruppo and Jeffrey Barnes.

CoNextions Medical specializes in innovative orthopedic solutions, primarily focusing on products designed for soft tissue repair, specifically tendon repairs. The company's flagship product, the Coronet System, is engineered to facilitate simultaneous fixation of soft tissue to bone, eliminating the need for traditional knot tying. By utilizing a stainless steel soft tissue washer, the system enhances resistance to soft tissue tear-through, thereby improving post-operative outcomes. CoNextions Medical’s offerings target healthcare professionals, including orthopedic surgeons, and are utilized in various settings, including hospitals and outpatient surgical centers.

The company markets its products across multiple regions, including the United States, Chile, Kuwait, and South Africa, aiming to address the common complications associated with tendon repairs. CoNextions Medical generates revenue through the sale of its medical devices, notably the trademarked Coronet System and the TR® Tendon Repair System. Transactions typically occur on a B2B basis, where hospitals and surgical centers procure these devices directly for surgical use. Pricing structures for these products are designed to reflect their innovative design and clinical advantages, which may include tiered pricing based on volume purchases by healthcare facilities.

This direct-to-consumer model ensures that surgeons have access to advanced technologies that improve surgical outcomes. The company’s focus on revolutionizing tendon repair through its products positions it as a specialized provider in the orthopedic medical device market. CoNextions Medical plans to expand its product line with upcoming innovations designed for enhanced tendon repair solutions, although specific product release dates have not been disclosed. The company aims to enter new markets, specifically targeting regions not yet fully serviced, to be identified in the coming years.

The recent funding of USD 1. 11 mn raised in December 2018 will support these initiatives, ensuring development and market entry are adequately financed.